Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Shahram Kordasti

Shahram Kordasti

MD, PhD
King’s College London
Novel therapeutic approaches in MPNs: targeting CALR, immune modulation, & JAKi specificity 9:53
Novel therapeutic approaches in MPNs: targeting CALR, immune modulation, & JAKi specificity
David Steensma et al. • 27 Jun 2025
The i4MDS consortium and immune monitoring in MDS 9:41
The i4MDS consortium and immune monitoring in MDS
Sanam Loghavi et al. • 13 Jun 2024
Understanding the role of inflammation and the immunome in MDS pathophysiology 2:06
Understanding the role of inflammation and the immunome in MDS pathophysiology
Shahram Kordasti • 5 Apr 2024
Immune checkpoint inhibitors in MDS: the i4MDS consortium 2:53
Immune checkpoint inhibitors in MDS: the i4MDS consortium
Shahram Kordasti • 5 Apr 2024
The role of immune checkpoint inhibitors in MDS 4:27
The role of immune checkpoint inhibitors in MDS
Shahram Kordasti • 22 Sep 2021
The immune system’s role in higher-risk MDS 6:05
The immune system’s role in higher-risk MDS
Shahram Kordasti • 22 Sep 2021
Immune dysregulation and drug selection in MDS 7:18
Immune dysregulation and drug selection in MDS
Shahram Kordasti • 27 Jan 2021
MDS biology: somatic mutations, the microenvironment & inflammation 5:36
MDS biology: somatic mutations, the microenvironment & inflammation
Shahram Kordasti • 27 Jan 2021
Immunological impact of TP53 in MDS 1:23
Immunological impact of TP53 in MDS
Shahram Kordasti • 27 Jan 2021
The content of VJHemOnc is intended for healthcare professionals